OraSure Technologies to Present at the Sixth Annual Needham & Company, LLC Biotechnology & Medical Technology Conference
Posted on: Friday, 8 June 2007, 12:00 CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Ronald H. Spair, Chief Operating Officer and Chief Financial Officer, will speak to the investment community at the Sixth Annual Needham & Company, LLC Biotechnology & Medical Technology Conference in New York City. The conference will be simultaneously webcast over the Internet.
Mr. Spair is scheduled to speak on June 13, 2007, at approximately 11:30 am Eastern Time (8:30 am Pacific Time). Interested investors can access the live audio webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the audio webcast will be available on OraSure Technologies' web site for seven days. Alternatively, you can access the live audio webcast of the presentation via the following link http://www.wsw.com/webcast/needham18/osur/.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid collection devices to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.
Source: Business Wire
Related Articles
- OraSure Technologies Supports Global and Domestic Rapid HIV Testing Initiatives for World AIDS Day
- StatSure Receives Order for 500,000 Oral Fluid Collection Devices
- StatSure Applies for Patent for New Oral Fluid Testing Device
- OraSure Technologies to Present at Pacific Growth Equities Life Sciences Growth Conference
- OraSure Technologies Appoints New Director
- Johns Hopkins Hospital Successfully Implements Routine Oral Fluid HIV Screening Program With OraQuick(R) ADVANCE(TM); OraQuick(R) ADVANCE(TM) Is Most Used Rapid HIV Test in Hospitals
- OraSure Technologies to Present at Needham & Company, LLC Growth Conference
- OraSure Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
- OraSure Technologies to Present Before the FDA Blood Products Advisory Committee on November 3, 2005
- OraSure Technologies Appoints New Chief Science Officer
 |
 |
User Comments (0)
RSS Feeds